BJP Try Advances in Psychiatric Treatment Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


The British Journal of Psychiatry (2006) 188: 586. doi: 10.1192/bjp.188.6.586-a
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katz, M. M.
Right arrow Articles by Bowden, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katz, M. M.
Right arrow Articles by Bowden, C. L.

Correspondence

‘Delay’ hypothesis of onset of antidepressant action

M. M. Katz

Department of Psychiatry, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78229-3900, USA.

A. Frazer

Department of Pharmacology, University of Texas Health Science Center at San Antonio, Texas, USA

C. L. Bowden

Department of Psychiatry, University of Texas Health Science Center at San Antonio, Texas, USA

Correspondence: E-mail: katzmm{at}verizon.net

EDITED BY KIRIAKOS XENITIDIS and COLIN CAMPBELL

The ‘delay’ hypothesis has had a long life and has greatly influenced the treatment of depression and research aimed at the development of new ‘more rapidly acting’ drugs. Evidence has gradually accumulated that the hypothesis is inaccurate and its entrance into the lore of clinical practice and textbooks is unwarranted. The hypothesis was derived from studies that did not test it directly and are now viewed as both conceptually and methodologically inadequate. In his editorial, Mitchell (2006) makes salient points and, after reviewing some of the current literature, comes to the correct conclusions. However, our earlier results that refuted the hypothesis (Katz et al, 1987, 1991) and a more recently published study (Katz et al, 2004), designed to definitively test the ‘delay’ notion, were not referenced. Their omission leaves important gaps.

Mitchell highlights the inadequacy of the ‘outcome’ measures used in early studies and the importance of distinguishing ‘improvement’ from ‘full response’. The central criticism of the early work (e.g. by Gelenberg & Chesen, 2000) is that most information was derived from clinical trials, not studies designed to accurately estimate onset and time course of changes. Such studies require a placebo control, sensitive measures of behavioural change (beyond the Hamilton Rating Scale for Depression) and frequent early assessment. The meta-analyses of Stassen et al (1997) came close to achieving these aims. However, no study had met all the necessary requirements until that conducted by our group (Katz et al, 2004). This measured the major behavioural components of the disorder intensively at 3-day intervals, operationally distinguished improvement and full response and compared pharmacologically different antidepressants (a selective serotonin reuptake inhibitor and a selective noradrenaline reuptake inhibitor) with placebo. In targeting the issue directly, it used appropriate statistical methods to investigate whether algorithms could be developed to predict treatment response from early behavioural changes, problems alluded to by Mitchell. We understand that an editorial cannot provide an exhaustive review but believe the information above will contribute to the important issues addressed.

REFERENCES

Gelenberg, A. J. & Chesen, C. L. (2000) How fast are antidepressants? Journal of Clinical Psychiatry, 61, 712 –721.[Medline]

Katz, M. M., Koslow, S. H., Maas, J. W., et al (1987) The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychological Medicine, 17, 297 –309.[Medline]

Katz, M. M., Koslow, S. H., Maas, J. W., et al (1991) Identifying the specific clinical actions of amitryptyline: Interrelationships of behavior, affect, and plasma levels in depression. Psychological Medicine, 21, 599 –611.[Medline]

Katz, M. M., Tekell, J. L., Bowden, C. L., et al (2004) Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology, 29, 566 –579.[CrossRef][Medline]

Mitchell, A. J. (2006) Two-week delay in onset of action of antidepressants: new evidence. British Journal of Psychiatry, 188, 105 –106.[Abstract/Free Full Text]

Stassen, H. H., Angst, J. & Delini-Stula, A. (1997) Delayed onset of action of antidepressants? Survey of recent results. European Psychiatry, 12, 166 –176.[CrossRef]





This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katz, M. M.
Right arrow Articles by Bowden, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katz, M. M.
Right arrow Articles by Bowden, C. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals